Contact
searchSearch
HMP Global

Dermatology Topic Center

interview


Advanced Squamous Cell Carcinoma of the Anal Canal
Videos
Evaluating Retifanlimab for Advanced Squamous Cell Carcinoma of the Anal Canal in the Frontline Setting
03/31/2026
Lingbin Meng, MD, PhD
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how adding retifanlimab to chemotherapy may reshape frontline treatment for advanced squamous cell carcinoma of the anal canal.
Lingbin Meng, MD, discusses how...
03/31/2026
Journal of Clinical Pathways
Edwards
Interview
Q&A – Incyte Ingenuity Awards in Vitiligo
10/26/2023
Todd Edwards
Todd Edwards, Group Vice President & Head of the Dermatology Business Unit at Incyte, delves into the topic of vitiligo. Drawing from his extensive 20+ years of experience in the pharmaceutical industry, which includes prominent leadership...
Todd Edwards, Group Vice President & Head of the Dermatology Business Unit at Incyte, delves into the topic of vitiligo. Drawing from his extensive 20+ years of experience in the pharmaceutical industry, which includes prominent leadership...
Todd Edwards, Group Vice...
10/26/2023
First Report Managed Care
Headshot of Gary Owens
Interview
An Overview of Vitiligo: Prevalence, Comorbidities, and Available Therapies
05/30/2023
Maria Asimopoulos
Gary Owens, MD, president of Gary Owens Associates, reviews the prevalence and burden associated with vitiligo as well as coverage considerations for a range of treatment options. 
Gary Owens, MD, president of Gary Owens Associates, reviews the prevalence and burden associated with vitiligo as well as coverage considerations for a range of treatment options. 
Gary Owens, MD, president of...
05/30/2023
First Report Managed Care
Headshot of Nikolaos Sideris, Aristotle University, Thessaloniki, Greece
Interview
The Future of Atopic Dermatitis: Comparative Studies, Biomarker Testing
11/01/2022
Maria Asimopoulos
Nikolaos Sideris, MD, PhD candidate-scientific associate, First Department of Dermatology, Aristotle University Medical School, Thessaloniki, Greece, reviews the current state of practice and research in atopic dermatitis, emphasizing the...
Nikolaos Sideris, MD, PhD candidate-scientific associate, First Department of Dermatology, Aristotle University Medical School, Thessaloniki, Greece, reviews the current state of practice and research in atopic dermatitis, emphasizing the...
Nikolaos Sideris, MD, PhD...
11/01/2022
First Report Managed Care
Headshot of Amy S Paller, MD, Northwestern University Feinberg School of Medicine
Interview
Topicals for Atopic Dermatitis: Optimizing Treatment Before Systemic Therapy
08/30/2022
Maria Asimopoulos
Amy S Paller, MD, chair, department of dermatology, Northwestern University, Feinberg School of Medicine, reviews available and incoming treatments for atopic dermatitis, as well as strategies to optimize the use of topicals before pursuing...
Amy S Paller, MD, chair, department of dermatology, Northwestern University, Feinberg School of Medicine, reviews available and incoming treatments for atopic dermatitis, as well as strategies to optimize the use of topicals before pursuing...
Amy S Paller, MD, chair,...
08/30/2022
First Report Managed Care
Headshot of Lawrence Green, MD
Interview
Treatment Considerations for Pediatric vs Adult Patients With Atopic Dermatitis
07/29/2022
Maria Asimopoulos
Lawrence J Green, MD, clinical professor of dermatology, George Washington University School of Medicine, reviews how clinicians approach treatment options for atopic dermatitis, as well as where the future of care my be headed as more agents...
Lawrence J Green, MD, clinical professor of dermatology, George Washington University School of Medicine, reviews how clinicians approach treatment options for atopic dermatitis, as well as where the future of care my be headed as more agents...
Lawrence J Green, MD, clinical...
07/29/2022
First Report Managed Care
Headshot of Katherine A Kelly, Wake Forest University
Interview
Research Demonstrates Efficacy, Safety of Tralokinumab for Atopic Dermatitis
07/15/2022
Maria Asimopoulos
Katherine A Kelly, Center for Dermatology Research, department of dermatology, Wake Forest School of Medicine, discusses findings showing the potential of tralokinumab to reduce symptom burden and boost quality of life in patients with atopic...
Katherine A Kelly, Center for Dermatology Research, department of dermatology, Wake Forest School of Medicine, discusses findings showing the potential of tralokinumab to reduce symptom burden and boost quality of life in patients with atopic...
Katherine A Kelly, Center for...
07/15/2022
First Report Managed Care
Headshot of Ed Pezalla, Enlightenment Bioconsult
Interview
Impact of New Atopic Dermatitis Treatments on Formulary Decision Making
05/27/2022
Maria Asimopoulos
Ed Pezalla, MD, MPH, chief executive officer, Enlightenment Bioconsult, LLC, reviews what payers should keep in mind regarding outcome measures and treatment guidelines as new therapies for atopic dermatitis continue hitting the market.
Ed Pezalla, MD, MPH, chief executive officer, Enlightenment Bioconsult, LLC, reviews what payers should keep in mind regarding outcome measures and treatment guidelines as new therapies for atopic dermatitis continue hitting the market.
Ed Pezalla, MD, MPH, chief...
05/27/2022
First Report Managed Care
Headshot of Dr Raj Chovatiya, assistant professor of dermatology, director of the Center for Eczema and Itch at the Northwestern University Feinberg School of Medicine
Interview
JAK Inhibitors, Monoclonal Antibodies, Corticosteroids: Choosing a Treatment for Atopic Dermatitis
05/25/2022
Maria Asimopoulos
Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, breaks down treatment options for atopic dermatitis and why clinicians may opt for one class of agents over another.
Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, breaks down treatment options for atopic dermatitis and why clinicians may opt for one class of agents over another.
Raj Chovatiya, MD, PhD,...
05/25/2022
First Report Managed Care

Pipeline Projections

PIPELINE PROJECTIONS
Emerging Therapies Reshaping Atopic Dermatitis Care
03/26/2026
Roy Moore
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly...
03/26/2026
First Report Managed Care
Pipe
Pipeline Projections
Emerging Migraine Treatments Challenge a Mature Market
11/20/2025
Roy Moore
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market...
11/20/2025
First Report Managed Care
Pipeline Projections
Pipeline Projections
Redefining Asthma Management With Emerging Anti-Inflammatories
10/01/2025
Roy Moore
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access...
10/01/2025
First Report Managed Care
Pipeline Projections
The Shift in MS Care as Biologics and BTK Inhibitors Advance
07/25/2025
Roy Moore
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline...
07/25/2025
First Report Managed Care
Pipeline Projections
How Biosimilars Are Shaping RA Treatment and Reimbursement Strategies
04/29/2025
Roy Moore
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline...
04/29/2025
First Report Managed Care

Subscribe to receive the latest updates in managed care!

First Report Managed Care Newsletter

Behind the Bill

Behind the Bill
HHS Hits Reset on 340B Rebate Model After Court Setbacks
02/11/2026
Juliet Gallagher
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and...
02/11/2026
First Report Managed Care
Behind the Bill
Funding Package Extends Medicare Telehealth, Enacts PBM Reforms, and Updates Hospital Oversight
02/05/2026
Juliet Gallagher
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President...
02/05/2026
First Report Managed Care
Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use